Clinical Trial Update: Drug-Drug Interaction Study of ABP-671 in Gout Patients [Phase 1]

View source ↗

Summary

A Phase 1 drug-drug interaction study of ABP-671 in gout patients is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout

Drugs mentioned

• ABP-671

Snippet

Sponsor: Atom Therapeutics Co., Ltd | Conditions: Gout Chronic, Gout | Phase 1 | Status: RECRUITING